DrugPatentWatch Database Preview
Mechanism of Action: P-Glycoprotein Inhibitors
» See Plans and Pricing
Drugs with Mechanism of Action: P-Glycoprotein Inhibitors
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novartis | ZORTRESS | everolimus | TABLET;ORAL | 021560-001 | Apr 20, 2010 | AB | RX | Yes | No | Start Trial | Start Trial | Start Trial | |||
Novartis | ZORTRESS | everolimus | TABLET;ORAL | 021560-002 | Apr 20, 2010 | AB | RX | Yes | No | Start Trial | Start Trial | Start Trial | |||
Novartis | ZORTRESS | everolimus | TABLET;ORAL | 021560-003 | Apr 20, 2010 | AB | RX | Yes | No | Start Trial | Start Trial | Start Trial | |||
Novartis | ZORTRESS | everolimus | TABLET;ORAL | 021560-004 | Aug 10, 2018 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
Glenmark Generics | ZONISAMIDE | zonisamide | CAPSULE;ORAL | 077651-002 | Jan 30, 2006 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
Glenmark Generics | ZONISAMIDE | zonisamide | CAPSULE;ORAL | 077651-003 | Jan 30, 2006 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
Sun Pharm Inds (in) | ZONISAMIDE | zonisamide | CAPSULE;ORAL | 077634-001 | Mar 17, 2006 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |